Discovery Research Articles

31. Decoding A B-Cell Fingerprint: All You Need To Know 7/30/2024

    Explore how, much like a fingerprint, each B-cell possesses a unique identity, and how deciphering this code can unlock a wealth of possibilities in antibody development, immunotherapy, and beyond.

32. Early Phase Bioassays And Analytics 6/26/2024

    The development of phase-appropriate, tailored bioassays is crucial. By identifying promising candidates, bioassays streamline the development process, enabling informed decision-making.

33. Compound Library Consortium 5/16/2024

    Explore how a novel approach to enhancing drug discovery efforts can significantly improve the chances of identifying promising drug candidates, ultimately accelerating the path from discovery to development.

34. Clear MRSA Infections At Single Low Doses 1/4/2024

    Multidrug-resistant bacteria are rendering antibiotics ineffective. Review preclinical results of a potent macrocycle derivative and why collaboration is crucial to transition discoveries into treatments.

35. ADCs: From Design To Development 1/4/2024

    Explore how a CDMO with specialized teams can support running different stages in parallel to facilitate data sharing and clear communication, ultimately taking your ADC from design to development.

36. Utilizing MAPPs For An Enhanced Assessment Of Immunogenicity 1/4/2024

    Explore how MAPPS demonstrates promise as a valuable tool for comprehensive immunogenicity assessment in therapeutic protein development, contributing to safer and more effective biologics.

37. Considerations And Strategies For Hiring Biopharma Consultants 12/8/2023

    Most organizations do not have the budget or workload to justify a team spanning all possible subspecialties. So, those gaps typically are filled with consultants who add clear value to delivering products and services for the company’s clients. But how do you find the right consultants?

38. Live Biotherapeutics And Next Gen Manufacturing 10/5/2023

    With services to develop and scale up Probiotics, Postbiotics and Microbial Therapeutics, explore how Sacco System’s capabilities can help take your drug product to market safely and efficiently.

39. Recommendations For Successful IND Approval Of RNA-LNP Drugs 8/22/2023

    The existing regulatory system is ambiguous for RNA therapeutics. Leverage this Investigational New Drug (IND) guide to help accelerate and strengthen the process IND filing of novel nanomedicines.

40. De-Risking Preclinical Candidates With Predictive Immunotoxicology 8/14/2023

    From target engagement and mechanism of action to efficacy and prediction of adverse immune reactions, immunology assays deliver data that reduce your risk of failing later.